HomeEurasian Translational Medicine Center

Eurasian Translational Medicine Center

In November 2023, in collaboration with the European Academy of Sciences, The Chinese University of Hong Kong, and others

Establishment of the Eurasian Translational Medicine Center (TEA-NET)

Assist the Guangdong Hong Kong Macao Greater Bay Area in becoming a global center for scientific and technological innovation transformation.

In November 2023, in collaboration with the European Academy of Sciences, The Chinese University of Hong Kong, and others

Establishment of the Eurasian Translational Medicine Center (TEA-NET)

Assist the Guangdong Hong Kong Macao Greater Bay Area in becoming a global center for scientific and technological innovation transformation.


In November 2023, in collaboration with the European Academy of Sciences, The Chinese University of Hong Kong, and others

Establishment of the Eurasian Translational Medicine Center (TEA-NET)

Assist the Guangdong Hong Kong Macao Greater Bay Area in becoming a global center for scientific and technological innovation transformation.


In November 2023, in collaboration with the European Academy of Sciences, The Chinese University of Hong Kong, and others

Establishment of the Eurasian Translational Medicine Center (TEA-NET)

Assist the Guangdong Hong Kong Macao Greater Bay Area in becoming a global center for scientific and technological innovation transformation.


International Cooperation

The CREATE has reached a comprehensive cooperation agreement with Cytiva, a global pioneer in the field of life sciences under Danaher, to jointly build a new paradigm of advanced therapeutic drug industry cooperation in the Greater Bay Area.



01

The CREATE has successfully established a comprehensive cooperation with Stimuliver, a regenerative therapy company founded by professors from the University of Edinburgh and grown in the Novo Nordisk incubator.


02

On December 23, 2024, the "Boehringer Ingelheim-CREATE Joint Innovation Incubator" was officially launched, becoming the first high-level innovation platform in the Greater Bay Area to be deeply cooperated between multinational pharmaceutical companies and innovation centers


03

The left image shows the head of the B cell laboratory at Bambino Gesu Hospital

Rita Carsetti at Shenzhen Institutes of Advanced Technology,Chinese Academy of Sciences


04
05

0755-66880601

No. 7, Qingshuihe 3rd Road, Luohu district, Shenzhen, China